EP0536360A4 - Topical treatment of acne - Google Patents
Topical treatment of acneInfo
- Publication number
- EP0536360A4 EP0536360A4 EP19920908796 EP92908796A EP0536360A4 EP 0536360 A4 EP0536360 A4 EP 0536360A4 EP 19920908796 EP19920908796 EP 19920908796 EP 92908796 A EP92908796 A EP 92908796A EP 0536360 A4 EP0536360 A4 EP 0536360A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- acne
- topical treatment
- topical
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66479591A | 1991-03-05 | 1991-03-05 | |
US664795 | 1991-03-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0536360A1 EP0536360A1 (en) | 1993-04-14 |
EP0536360A4 true EP0536360A4 (en) | 1993-08-04 |
Family
ID=24667469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19920908796 Withdrawn EP0536360A4 (en) | 1991-03-05 | 1992-03-03 | Topical treatment of acne |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0536360A4 (en) |
AU (1) | AU656097B2 (en) |
CA (1) | CA2086259A1 (en) |
WO (1) | WO1992015299A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5627195A (en) * | 1995-04-11 | 1997-05-06 | Massachusetts Eye And Ear Infirmary | Treatment for ocular inflammation |
WO2004080179A1 (en) * | 2003-03-10 | 2004-09-23 | Xantech Pharmaceuticals, Inc. | Surface sanitizing compositions with improved antimicrobial performance |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2287223A1 (en) * | 1974-10-10 | 1976-05-07 | Beecham Group Ltd | PHARMACEUTICAL COMPOSITION |
FR2378523A1 (en) * | 1977-01-26 | 1978-08-25 | Grupper Charles | ACNE TREATMENT MEDICINE |
EP0008525A2 (en) * | 1978-08-25 | 1980-03-05 | Beecham Group Plc | Pharmaceutical compositions and process for their preparation |
EP0296740A2 (en) * | 1987-06-11 | 1988-12-28 | Skandigen Ab | Hyaluronic acid derivatives and their production |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444755A (en) * | 1978-01-23 | 1984-04-24 | Efamol Limited | Treatment for skin disorders |
US4954487A (en) * | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
-
1992
- 1992-03-03 EP EP19920908796 patent/EP0536360A4/en not_active Withdrawn
- 1992-03-03 CA CA002086259A patent/CA2086259A1/en not_active Abandoned
- 1992-03-03 AU AU15800/92A patent/AU656097B2/en not_active Ceased
- 1992-03-03 WO PCT/US1992/001405 patent/WO1992015299A1/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2287223A1 (en) * | 1974-10-10 | 1976-05-07 | Beecham Group Ltd | PHARMACEUTICAL COMPOSITION |
FR2378523A1 (en) * | 1977-01-26 | 1978-08-25 | Grupper Charles | ACNE TREATMENT MEDICINE |
EP0008525A2 (en) * | 1978-08-25 | 1980-03-05 | Beecham Group Plc | Pharmaceutical compositions and process for their preparation |
EP0296740A2 (en) * | 1987-06-11 | 1988-12-28 | Skandigen Ab | Hyaluronic acid derivatives and their production |
Non-Patent Citations (1)
Title |
---|
See also references of WO9215299A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU1580092A (en) | 1992-10-06 |
WO1992015299A1 (en) | 1992-09-17 |
CA2086259A1 (en) | 1992-09-06 |
AU656097B2 (en) | 1995-01-19 |
EP0536360A1 (en) | 1993-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA945545B (en) | Psoriasis treatment | |
GB9215633D0 (en) | Novel treatment | |
PH25291A (en) | Acne treatment | |
EP0559791A4 (en) | Treatment of topical infections | |
AU3236093A (en) | The use of ob-101 to treat inflammation | |
AU3235693A (en) | The use of ob-104 to treat inflammation | |
GB9203039D0 (en) | Treatment | |
GB9211148D0 (en) | Novel treatment | |
GB2271579B (en) | Treatment of wood | |
GB9222260D0 (en) | Skin treatment | |
GB9201920D0 (en) | Novel treatment i | |
GB8808247D0 (en) | Treatment of prophylaxis of acne dandruff/related conditions | |
EP0536360A4 (en) | Topical treatment of acne | |
GB9218711D0 (en) | Skin cancer treatment | |
NZ255753A (en) | Use of substituted azaspiranes for psoriasis treatment | |
AP9300527A0 (en) | Novel treatment | |
GB9218773D0 (en) | Skin treatment | |
GB9103098D0 (en) | Dermatological treatment | |
ZA891541B (en) | Acne treatment | |
AU663868B2 (en) | Treatment for acne | |
GB9308572D0 (en) | Topical lotion for the treatment of alopecia | |
IE890675L (en) | Acne treatment | |
GB9117210D0 (en) | Treatment of cancer | |
BG98118A (en) | Methods of psoriasis treatment | |
RU1833736C (en) | Means of treatment of psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE ES FR GB IT LI NL SE |
|
17P | Request for examination filed |
Effective date: 19930316 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19930614 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE ES FR GB IT LI NL SE |
|
17Q | First examination report despatched |
Effective date: 19970721 |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/43 A, 7A 61K 31/545 B, 7A 61P 17/10 B |
|
RTI1 | Title (correction) |
Free format text: PHARMACEUTICAL COMPOSITION FOR USE FOR THE TOPICAL TREATMENT OF ACNE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/43 A, 7A 61K 31/545 B, 7A 61P 17/10 B |
|
RTI1 | Title (correction) |
Free format text: PHARMACEUTICAL COMPOSITION FOR USE FOR THE TOPICAL TREATMENT OF ACNE |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030114 |